+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Motion Sickness Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4850969
  • Report
  • May 2018
  • Region: Global
  • 166 pages
  • Transparency Market Research
1 of 2

Global Motion Sickness Treatment Market: Overview

Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by difference in impulses received by perceived sense of motion by visual senses and vestibular system’s sense of movement. Conflict among those senses result in motion sickness. Motion sickness is estimated to be experienced by around 50% travelers; it is most widely witnessed among children and elderly people. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from its symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications, while traditional remedies such as herbal medicines, homeopathic medicines, and others are also available as OTC products for treatment of motion sickness.

The global motion sickness treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on treatment type, route of administration, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market has been provided in the overview section. The report provides key insights of the global motion sickness treatment market comprising global pipeline analysis, key mergers and acquisitions, OTC vs. prescription drug market assessment, and Porter’s Five Forces Analysis. Additionally, the competition landscape section comprises competitive matrix, key player’s market footprint by treatment type and region, key competitive business strategies, and company profiles with business overview to understand the competitive landscape in the market. The report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global motion sickness treatment market.

Global Motion Sickness Treatment Market: Key Segments

Based on treatment type, the global motion sickness treatment market has been segmented into anticholinergic, antihistamines, and others. The report also offers overview of the global motion sickness treatment market based on oral, transdermal, and other routes of administration. The treatment type segments have been analyzed based on commercially available motion sickness treatment drug and product types, route of administration, and adoption of each treatment type. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of distribution channel, the global motion sickness treatment market has been segmented into retail pharmacies, online pharmacies, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Motion Sickness Treatment Market: Regional Outlook

Geographically, the global motion sickness treatment market has been segmented into five major regions and the key countries/sub-regions in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the motion sickness treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands, Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Inc., Myungmoon Pharm Co., Ltd., Baxter International, Inc. and Reliefband Technologies LLC.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Motion Sickness Treatment Market

4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.1. Restraints
4.3. Global Motion Sickness Treatment Market Analysis and Forecast, 2016-2026
4.3.1. Market Revenue Projections (US$ Mn)
4.4. Porter’s Five Force Analysis

5. Market Outlook
5.1.Pipeline Analysis
5.2.Key Mergers & Acquisitions
5.3.OTC & Prescription Market Analysis

6. Global Motion Sickness Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2016-2026
6.3.1. Anticholinergic
6.3.2. Antihistamines
6.3.3. Others
6.4. Market Attractiveness, by Treatment Type

7. Global Motion Sickness Treatment Market Analysis and Forecasts, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Route of Administration, 2016-2026
7.3.1. Oral
7.3.2. Transdermal
7.3.3. Others
7.4. Market Attractiveness, by Route of Administration

8. Global Motion Sickness Treatment Market Analysis and Forecasts, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2016-2026
8.3.1. Retail Pharmacies
8.3.2. Online Pharmacies
8.3.3. Others
8.4. Market Attractiveness, by Distribution Channel

9. Global Motion Sickness Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region

10. North America Motion Sickness Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2016-2026
10.2.1. Anticholinergic
10.2.2. Antihistamines
10.2.3. Others
10.3. Market Value Forecast, by Route of Administration, 2016-2026
10.3.1. Oral
10.3.2. Transdermal
10.3.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2016-2026
10.4.1. Retail Pharmacies
10.4.2. Online Pharmacies
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016-2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Motion Sickness Treatment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Treatment Type, 2016-2026
11.2.1. Anticholinergic
11.2.2. Antihistamines
11.2.3. Others
11.3.Market Value Forecast, by Route of Administration, 2016-2026
11.3.1. Oral
11.3.2. Transdermal
11.3.3. Others
11.4.Market Value Forecast, by Distribution Channel, 2016-2026
11.4.1. Retail Pharmacies
11.4.2. Online Pharmacies
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016-2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Motion Sickness Treatment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Treatment Type, 2016-2026
12.2.1. Anticholinergic
12.2.2. Antihistamines
12.2.3. Others
12.3.Market Value Forecast, by Route of Administration, 2016-2026
12.3.1. Oral
12.3.2. Transdermal
12.3.3. Others
12.4.Market Value Forecast, by Distribution Channel, 2016-2026
12.4.1. Retail Pharmacies
12.4.2. Online Pharmacies
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016-2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Motion Sickness Treatment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Treatment Type, 2016-2026
13.2.1. Anticholinergic
13.2.2. Antihistamines
13.2.3. Others
13.3.Market Value Forecast, by Route of Administration, 2016-2026
13.3.1. Oral
13.3.2. Transdermal
13.3.3. Others
13.4.Market Value Forecast, by Distribution Channel, 2016-2026
13.4.1. Retail Pharmacies
13.4.2. Online Pharmacies
13.4.3. Others
13.5.Market Value Forecast, by Country, 2016-2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Motion Sickness Treatment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Treatment Type, 2016-2026
14.2.1. Anticholinergic
14.2.2. Antihistamines
14.2.3. Others
14.3.Market Value Forecast, by Route of Administration, 2016-2026
14.3.1. Oral
14.3.2. Transdermal
14.3.3. Others
14.4.Market Value Forecast, by Distribution Channel, 2016-2026
14.4.1. Retail Pharmacies
14.4.2. Online Pharmacies
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016-2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1.Market Player - Competition Matrix (By Tier and Size of companies)
15.2.Market Footprint Analysis
15.2.1. By Region
15.2.2. By Treatment Type
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. GlaxoSmithKline plc
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2.Product Portfolio
15.4.1.3.Financial Overview
15.4.1.4.SWOT Analysis
15.4.1.5.Strategic Overview
15.4.2. Perrigo Company plc
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2.Product Portfolio
15.4.2.3.Financial Overview
15.4.2.4.SWOT Analysis
15.4.2.5.Strategic Overview
15.4.3. Prestige Brands, Inc.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2.Product Portfolio
15.4.3.3.Financial Overview
15.4.3.4.SWOT Analysis
15.4.3.5.Strategic Overview
15.4.4. Wellspring Pharmaceutical Corporation
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2.Product Portfolio
15.4.4.3.SWOT Analysis
15.4.4.4.Strategic Overview
15.4.5. Caleb Pharmaceuticals, Inc.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2.Product Portfolio
15.4.5.3.SWOT Analysis
15.4.5.4.Strategic Overview
15.4.6. Myungmoon Pharm CO., LTD.
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2.Product Portfolio
15.4.6.3.Financial Overview
15.4.6.4.SWOT Analysis
15.4.6.5.Strategic Overview
15.4.7. Baxter International Inc.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2.Product Portfolio
15.4.7.3.Financial Overview
15.4.7.4.SWOT Analysis
15.4.7.5.Strategic Overview
15.4.8. Reliefband Technologies LLC
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2.Product Portfolio
15.4.8.3.Financial Overview
15.4.8.4.SWOT Analysis
15.4.8.5.Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll